U.S. Transportation Stock News

Index removals put Universal Insurance Holdings under the spotlight Universal Insurance Holdings (UVE) has been dropped from several Russell growth and microcap indexes, a change that can influence how passive funds treat the stock and affect trading liquidity. For you as an investor, these index removals are mostly about technical flows rather than any direct change to Universal Insurance Holdings operations or balance sheet. However, the shifts in ownership can still matter for the share...

AirJoule Technologies (AIRJ) has drawn fresh attention after unveiling its full-scale AirJoule Prime system in Newark, Delaware, where it is already operating and preparing for deployment into a European data center environment. See our latest analysis for AirJoule Technologies. Those watching AirJoule Technologies have seen short term swings, with the 1 day share price return down 6.66% after the Prime unveiling and a 7 day share price return of 6.03%. Over longer periods, a 90 day share...

Why the Haystack MRD approval matters for Quest Diagnostics stock Quest Diagnostics (DGX) just received New York State approval for its Haystack MRD liquid biopsy test, clearing clinical use across all 50 states and expanding the company’s reach in advanced cancer diagnostics. See our latest analysis for Quest Diagnostics. Alongside the Haystack MRD approval and Attunio Health partnership, Quest Diagnostics shares have climbed, with a year to date share price return of 24.13% and a 5 year...

Glass House Brands recently uplisted to the New York Stock Exchange under the ticker GLAS after restructuring its operations around medical cannabis and moving its adult-use businesses into a wholly owned subsidiary. This shift, coming after federal rescheduling of medical cannabis to Schedule III, reshapes Glass House’s business profile and potential market access, including future interstate and European opportunities. Next, we’ll examine how Glass House’s NYSE uplisting and medical focus...

In late June 2026, 10x Genomics, Inc. was removed from several Russell value benchmarks, including the Russell 2000 Value and Russell 3000 Value indexes. This broad index exclusion can matter for investors because it often triggers selling by index-tracking funds, altering trading flows without any direct change to the company’s operations. We’ll explore how 10x Genomics’ removal from multiple Russell value indexes may influence its existing investment narrative built around product...

DICK'S Sporting Goods (DKS) refreshed its ScoreCard loyalty program, introducing ScoreCard+, a US$99 per year paid tier that offers free standard shipping, quarterly rewards, service discounts, and targeted perks tied to owned brands and its credit card. See our latest analysis for DICK'S Sporting Goods. At a share price of US$236.18, DICK'S Sporting Goods has a 30 day share price return of 9.94% and a 90 day share price return of 18.29%. Its 5 year total shareholder return of 171.99% points...

Index reshuffle puts Agios Pharmaceuticals in the growth spotlight Agios Pharmaceuticals (AGIO) has shifted index buckets, dropping from the Russell 2000 Value-Defensive and Defensive indices while being added to several Russell growth benchmarks on 27 June 2026. This reclassification places Agios Pharmaceuticals alongside companies screened for growth characteristics across the Russell 2000 Growth, Russell 3000 Growth, Russell 3000E Growth, Russell 2500 Growth, and Russell Small Cap Comp...

Inter & Co recently opened a regulated U.S. banking branch in Miami and continued reshaping its loan book toward more secured, lower-risk credit, reinforcing its position as a full-service digital super app across Brazil and the United States. This combination of U.S. expansion and a more collateralized credit portfolio could meaningfully influence its funding profile, risk mix, and long-term profitability goals. We’ll now examine how the new Miami banking branch and international push could...

NETSTREIT (NTST) is drawing fresh attention after reports of the highest short interest among mid and large cap U.S. REITs, along with valuation concerns and recent insider selling. See our latest analysis for NETSTREIT. Against this backdrop of elevated short interest, NETSTREIT’s recent share price performance has been firm, with a year to date share price return of 21.89% and a 1 year total shareholder return of 32.79%. This suggests momentum has been building despite its removal from the...

AdaptHealth Corp. recently reported a cybersecurity breach in its cloud-based applications after a social engineering attack on a third-party contractor exposed certain patient and internal systems data, though it said Social Security numbers and financial accounts were not accessed. The incident highlights how vulnerabilities at external vendors can create operational and regulatory risks for healthcare providers, even when core financial identifiers remain protected. We’ll now examine how...

Capri Holdings Limited was recently reclassified within several Russell indices, added to multiple growth benchmarks and removed from value benchmarks, while also amending its revolving credit facility by reducing total commitments to US$1.00 billion and extending maturity to June 24, 2031. This shift from value to growth indices, combined with a longer-dated, multi-currency secured credit line, highlights how investors and lenders are reassessing Capri’s profile across style factors and...

Earlier this week, Donaldson Company reported fiscal 2026 third-quarter results with adjusted earnings and revenue exceeding analyst estimates and rising from a year ago, while guiding for full-year adjusted EPS of $3.94–$4.01 and organic sales growth of 3–5% across its segments. A key takeaway for investors is the especially strong outlook for the higher-growth Life Sciences segment, where management is targeting 9–11% sales growth, potentially shifting the company’s overall business mix...

GlobalFoundries recently announced that its SLATE wafer-to-wafer bonding technology is now production ready on the 9SW radio-frequency silicon-on-insulator platform at its 300mm Singapore fab, enabling 3D integration for compact, high-performance cellular front-ends and targeting volume production by the second half of 2027. This first-generation SLATE capability, which can shrink overall die size by up to 45% and supports a roadmap for heterogeneous 3D integration across FD-SOI, RF SOI and...

Winmark (WINA) has extended its partnership with CCM Hockey for three years, keeping its sustainability-focused trade-in program at the center of the Play It Again Sports franchise network and investor attention. See our latest analysis for Winmark. For investors tracking the bigger picture, Winmark’s share price has moved to $424.29, with a 30 day share price return of 12.37%, while its 1 year total shareholder return of 17.13% sits alongside a 5 year total shareholder return of 156.21%,...

In recent months, Entegris has drawn fresh attention as a key supplier of ultra-pure materials and filtration solutions for advanced nanochips used in AI and quantum computing, amid rising capital investment plans by major semiconductor manufacturers. This spotlight underscores how Entegris’ exposure to AI-related chip production and next-generation fabrication processes is increasingly central to its long-term business appeal. We’ll now examine how Entegris’ growing role in AI-related chip...

In June 2026, WeRide Inc., Geely Farizon New Energy Commercial Vehicle Group and Kwoon Chung Bus Holdings Limited announced a partnership to jointly develop and deploy purpose-built right-hand-drive Robotaxis, beginning commercial operations in Hong Kong and targeting wider right-hand-drive markets worldwide. This move gives WeRide a tailored product for right-hand-drive systems and dual capabilities across both traffic configurations, potentially broadening its global autonomous mobility...

Vestis (VSTS) is in the middle of a multi year transformation framework centered on Commercial Excellence, Operational Excellence, and Asset & Network Optimization, with fiscal 2026 positioned as a key execution year. See our latest analysis for Vestis. Against the backdrop of this transformation plan, Vestis shares have cooled slightly in the very near term, with a 1 day share price return of 2.72% and a 7 day share price return of 0.97%. However, the 30 day and 90 day share price returns of...

In late June 2026, Leidos Holdings announced a partnership with The Modern Data Company to embed DataOS into its HeadWay Mission OS, and was also added to the Russell 1000 Defensive and Russell 1000 Value-Defensive Indexes. This combination of an AI-native federal data offering and new inclusion in defensive indexes underscores Leidos’ push to deepen digital modernization exposure. Next, we’ll examine how embedding DataOS into HeadWay Mission OS may influence Leidos’ investment narrative and...

In Q1 2026, Nomad Foods reported a 5.9% year-over-year revenue decline and margin pressure tied to inventory and order realignment with retailers, but still exceeded analyst forecasts and kept its full-year guidance intact. An interesting angle is that, despite softer sales, Nomad Foods improved cash flow conversion and returned €45 million to shareholders through buybacks and dividends, underlining its focus on capital discipline. We’ll now explore how beating expectations while maintaining...

The live service model that once helped power hits like Destiny 2 is now under pressure, and that shift is rippling through gaming stocks. As Bungie, owned by Sony, pulls back on Destiny 2 updates and the industry leans toward blockbuster single player titles, investors are reassessing where future cash flows might come from. This article explains how that news connects to three stocks exposed to the same forces, highlighting one where the changing model could be a relative positive and two...

Teleflex (TFX) has drawn fresh attention after announcing the start of enrollment for its global BIOMAG-III Study, along with key milestones in the earlier BIOMAG trials assessing the Freesolve Resorbable Magnesium Scaffold. See our latest analysis for Teleflex. Teleflex shares have picked up momentum recently, with a 16.47% 90 day share price return and a 13.03% 1 year total shareholder return, although the 3 and 5 year total shareholder returns show sizeable declines. If this kind of...

On 27 June 2026, Doximity, Inc. (NYSE:DOCS) was removed from several Russell growth indices and added to multiple Russell value and value‑defensive benchmarks, including the Russell 1000 Value, Russell Midcap Value and Russell 3000 Value. This wholesale shift from growth to value indices reframes how Doximity is categorized by index providers, potentially changing which institutional investors track the stock and how its risk profile is perceived. We’ll now examine how Doximity’s...

Amylyx Pharmaceuticals was removed in late June 2026 from multiple Russell equity indexes, while also reporting initial Phase 1 LUMINA data showing AMX0114 was generally well tolerated at the lowest dose in people living with ALS. The combination of broad index deletions and early but encouraging ALS safety data highlights how technical trading flows and pipeline progress can pull Amylyx’s story in different directions at the same time. Now we’ll examine how early Phase 1 LUMINA safety...

New strategy chief puts recent leadership moves at First Busey in focus First Busey (BUSE) has appointed Mike Daley as chief strategy officer after he led Finance & Business Line Strategy during the bank's integration with CrossFirst Bank last year, putting its leadership approach in the spotlight for investors. See our latest analysis for First Busey. Beyond this leadership change, First Busey’s recent 7.5% 1 month share price return and 24.1% year to date share price return, alongside a...